Abstract
The macrophage electrophoretic migration test (MEM test) of Field and Caspary was used to study the sensitization to tumor antigens of blood lymphocytes of patients with solid tumor (7), chronic lymphatic leukemia (3), and Hodgkin's disease (8). Our preliminary results are partially in keeping with those of the English authors: blood lymphocytes from some patients with malignant neoplasm seem to be sensitised to crude cancer material irrespective of the type of the tumor from which it derives. The MEM test was negative in the 4 patients with Hodgkin's disease in remission and positive in the 4 patients with active disease. It is believed that further studies are needed before accepting this test as an in vitro diagnostic test for cancer.
Get full access to this article
View all access options for this article.